Christopher Pazdan - 12 May 2025 Form 4 Insider Report for KORU Medical Systems, Inc. (KRMD)

Reporting relationship: Chief Operating Officer
Issuer ticker: KRMD
Reported as of: 12 May 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 11 Aug 2025, 16:25:19 UTC
Prior SEC filing: 21 Mar 2025
Next SEC filing: 18 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Thomas Adams-Attorney-in- Fact

Key filing fact

Christopher Pazdan filed Form 4 for KORU Medical Systems, Inc. (KRMD) on 11 Aug 2025.

Key facts

This page summarizes Christopher Pazdan's Form 4 filing for KORU Medical Systems, Inc. (KRMD).
3 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 11 Aug 2025, 16:25.

Change

Previous filing in this sequence was filed on 21 Mar 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002028813 Primary reporting owner

Pazdan Christopher

Relationship: Chief Operating Officer
Address: C/O KORU MEDICAL SYSTEMS, INC., 100 CORPORATE DRIVE, MAHWAH
Signature: /s/ Thomas Adams-Attorney-in- Fact
Signature date: 07 Aug 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

KRMD transaction Derivative

Restricted Stock Units

Award

Transaction value: $0
Shares: +21,308
Change %
Price: $0.000000
Shares after: 21,308
Date: 12 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 21,308
Exercise price
Footnotes: F1, F2, F3

KRMD transaction Derivative

Restricted Stock Units

Award

Transaction value: $0
Shares: +21,308
Change %
Price: $0.000000
Shares after: 21,308
Date: 12 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 21,308
Exercise price
Footnotes: F1, F2, F4

KRMD transaction Derivative

Option to buy Common Stock

Award

Transaction value: $0
Shares: +36,077
Change %
Price: $0.000000
Shares after: 36,077
Date: 12 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 36,077
Exercise price: $3.21
Footnotes: F1, F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Each of the reported securities represent awards made pursuant to the Company's 2024 Omnibus Equity Incentive Plan in connection with the Company's 2025 Long-Term Incentive Program.

Footnote F2

Each restricted stock unit represents a contingent right to receive one share of KORU Medical Systems, Inc. (the "Company") upon vesting.

Footnote F3

One-fourth will vest on May 12, 2026 and on each first, second and third anniversary thereof or upon an earlier chance in control of the Company.

Footnote F4

These restricted stock units will vest based upon achievement of certain performance conditions as of December 31, 2027 or upon an earlier change in control of the Company. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-150% of the amount reported depending on the level of performance achieved, multiplied by between 0.5 to 1.5 times of the earned number of shares. These restricted stock units will vest at 100% of the amount reported upon a change in control of the Company prior to December 31, 2027.

Footnote F5

One-fourth will vest on May 12, 2026 and on each first, second and third anniversary thereof.

SEC remarks

The filing of this statement shall not be construed as an admission (a) that the person filing this statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this statement, or (b) that this statement is legally required to be filed by such person. Power of Attorney has been previously filed.